Comprehensive bioinformatics analysis of mRNA expression profiles and identification of a miRNA-mRNA network associated with lupus nephritis.
CONCLUSION: In summary, this study reveals some crucial genes and pathways potentially involving in the pathogenesis of LN. These findings provide a new insight for the research and treatment of LN. PMID: 32437257 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - May 21, 2020 Category: Rheumatology Authors: Song J, Zhao L, Li Y Tags: Lupus Source Type: research

Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
CONCLUSIONS: Long-term outcomes in terms of patient and renal survival of LN patients treated with CYP and MMF induction are similar. Doubling of serum creatinine occurred more with AZA-based maintenance therapy than with MMF-based maintenance therapy. Most deaths occurred during induction, and sepsis was the most common cause of death. PMID: 32437258 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - May 21, 2020 Category: Rheumatology Authors: Prasad N, Kurian J, Agarwal V, Bhadauria D, Behera M, Yacha M, Kushwaha R, Agrawal V, Jain M, Gupta A Tags: Lupus Source Type: research

In memoriam: Luis R. Espinoza, MD: (3 July 1943-29 March 2020).
;n GS PMID: 32408847 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - May 15, 2020 Category: Rheumatology Authors: Alarcón GS Tags: Lupus Source Type: research

Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis.
CONCLUSION: This study showed that there was alternative complement pathway limited activation in the renal tissue in a small number of patients with LN, and these patients had worse renal outcomes compared to patients with glomerular classical complement pathway activation with or without alternative pathway activation. PMID: 32408850 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - May 14, 2020 Category: Rheumatology Authors: Kim H, Kim T, Kim M, Lee HY, Kim Y, Kang MS, Kim J Tags: Lupus Source Type: research

Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies.
CONCLUSIONS: Herpes zoster reactivation is common in lupus nephritis patients but unpredictable from clinical parameters. Although adverse outcomes of herpes zoster infection are uncommon, using the minimally effective doses of mycophenolate mofetil and cyclophosphamide during induction therapy may help reduce the risk of herpes zoster infection. PMID: 32408851 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - May 14, 2020 Category: Rheumatology Authors: Mok CC, Tse SM, Chan KL, Ho LY Tags: Lupus Source Type: research

Severe pneumonia in Chinese patients with systemic lupus erythematosus.
CONCLUSION: Severe pneumonia is not rare in lupus, and is associated with high mortality and poor prognosis. Monitoring CD4+ T-cell counts and giving a small dose of glucocorticoids can reduce the occurrence of severe pneumonia and improve the prognosis of patients with lupus. PMID: 32403979 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - May 13, 2020 Category: Rheumatology Authors: Peng L, Wang Y, Zhao L, Chen T, Huang A Tags: Lupus Source Type: research

Hepatic manifestations in systemic lupus erythematosus.
ndez-Cano VH, Macías-Rodríguez RU Abstract Systemic lupus erythematosus (SLE) is a multi-organic autoimmune disease with a wide variety of clinical manifestations. However, hepatic dysfunction is not included in the diagnostic criteria for the disease and has not been recognized properly. The spectrum of hepatic involvement described in these patients ranges from abnormalities in liver function tests (LFTs) to fulminant hepatic failure. Usually, abnormalities in LFTs are only mild and transient, have a hepatocellular pattern and are not related to SLE but rather are mostly drug related. The most freq...
Source: Lupus - May 9, 2020 Category: Rheumatology Authors: González-Regueiro JA, Cruz-Contreras M, Merayo-Chalico J, Barrera-Vargas A, Ruiz-Margáin A, Campos-Murguía A, Espin-Nasser M, Martínez-Benítez B, Méndez-Cano VH, Macías-Rodríguez RU Tags: Lupus Source Type: research

Association of interleukin-17A gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multi-centre study.
CONCLUSION: The IL-17 rs2275913 A allele and A/A genotype were associated with high IL-17 serum levels and may contribute to susceptibility to JSLE and the development of LN in Egyptian children and adolescents. However, no significant association was evident between the studied IL-17A SNPs and other clinical phenotypes, disease activity scores or laboratory profile of JSLE. PMID: 32380889 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - May 7, 2020 Category: Rheumatology Authors: Elkoumi MA, Allah MA, Mohamed FY, Boraey NF, Abdellatif SH, Shehab MM, Sherif AH, Akeel NE, Saleh RM, Elshreif AM, Abdelrahman HM, Soliman AA, Emam AA, Youssef MA, Fahmy DS, Sallam MM, Nawara AM, Elgohary EA, Ismael A, El-Kaffas SM, Sobeih AA, Ibrahim LM, Tags: Lupus Source Type: research

Effect of early eradication therapy on systemic lupus erythematosus risk in patients with Helicobacter pylori infection: a nationwide population-based cohort study.
CONCLUSION: Early HP eradication could significantly reduce SLE risk, especially in the first three-year follow-up. PMID: 32380890 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - May 7, 2020 Category: Rheumatology Authors: Wu MC, Huang JY, Chen HH, Wei JC Tags: Lupus Source Type: research

Discoid lupus erythematosus of the lip: a case of refractory cheilitis.
ro RR PMID: 32375573 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - May 6, 2020 Category: Rheumatology Authors: João AL, Brasileiro A, Neves JM, Lencastre A, Pinheiro RR Tags: Lupus Source Type: research

Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus.
CONCLUSION: Hyperpigmented macules in the buccal mucosa in lupus patients receiving antimalarial treatment are not frequent and do not represent a predictive finding of toxicity of the drug. PMID: 32362181 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - May 3, 2020 Category: Rheumatology Authors: Chacón-Dulcey V, López-Labady J, Villarroel-Dorrego M, Frías J, Tirado W, González N, Pérez Alfonzo R Tags: Lupus Source Type: research

Prevalence and influential factors of thrombocytopaenia in systemic lupus erythematosus patients: a retrospective analysis of 3140 cases in a Chinese population.
Abstract INTRODUCTION: The present study aimed to investigate the prevalence and influential factors of thrombocytopaenia in systemic lupus erythematosus (SLE) patients among the Chinese population in order to provide evidence for improving the treatment and nursing of SLE patients. METHODS: A retrospective analysis of 3140 SLE patients admitted to two large tertiary hospitals was conducted in Anhui, China, from 2011 to 2018. In addition, the influential factors related to SLE with thrombocytopaenia were analysed through univariate and multivariate analysis. RESULTS: A total of 804 SLE patients had throm...
Source: Lupus - May 1, 2020 Category: Rheumatology Authors: Mao YM, Shi PL, Wu L, Hu YQ, He YS, Xiang K, Tao JH, Pan HF, Wu GC Tags: Lupus Source Type: research

Diaphragmatic muscle thickness and diaphragmatic function are reduced in patients with systemic lupus erythematosus compared to those with primary Sj ögren's syndrome.
Diaphragmatic muscle thickness and diaphragmatic function are reduced in patients with systemic lupus erythematosus compared to those with primary Sjögren's syndrome. Lupus. 2020 Apr 26;:961203320919848 Authors: Satış H, Cindil E, Salman RB, Yapar D, Temel E, Demir NB, Babaoğlu H, Gündoğdu O, Ataş N, Şendur H, Avanoğlu Güler A, Karadeniz H, Tufan A, Öztürk MA, Haznedaroğlu Ş, Göker B PMID: 32338144 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 26, 2020 Category: Rheumatology Authors: Satış H, Cindil E, Salman RB, Yapar D, Temel E, Demir NB, Babaoğlu H, Gündoğdu O, Ataş N, Şendur H, Avanoğlu Güler A, Karadeniz H, Tufan A, Öztürk MA, Haznedaroğlu Ş, Göker B Tags: Lupus Source Type: research

Physiopathology of pain in systemic erythematosus lupus.
PMID: 32323601 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 23, 2020 Category: Rheumatology Authors: Nichilatti LP, Fernandes JM, Marques CP Tags: Lupus Source Type: research

Systemic lupus erythematosus-associated diffuse alveolar hemorrhage: a single-center, matched case-control study in China.
PMID: 32321345 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 22, 2020 Category: Rheumatology Authors: Sun Y, Zhou C, Zhao J, Wang Q, Xu D, Zhang S, Shen M, Hou Y, Tian X, Li M, Zeng X Tags: Lupus Source Type: research

Hsa_circ_0012919 regulates expression of MDA5 by miR-125a-3p in CD4+ T cells of systemic lupus erythematous.
PMID: 32321346 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 22, 2020 Category: Rheumatology Authors: Zhang C, Zhang C, Ji J, Xiong X, Lu Y Tags: Lupus Source Type: research

Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
PMID: 32316844 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 21, 2020 Category: Rheumatology Authors: Aduriz-Lorenzo PM, Aduriz-Llaneza P, Araiz-Iribarren J, Khamashta MA Tags: Lupus Source Type: research

Rapidly progressive glomerulonephritis due to systemic lupus erythematosus and ANCA-associated vasculitis overlap.
PMID: 32316845 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 21, 2020 Category: Rheumatology Authors: Farah RI, Shahin NA, Alawneh M, Adwan M Tags: Lupus Source Type: research

Disease activity-dependent expression of nerve growth factor TRKA and P75 receptors on elevated dendritic cells and peripheral leucocytes in patients with systemic lupus erythematosus.
PMID: 32316846 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 21, 2020 Category: Rheumatology Authors: Welle S, Wolf AM, Dernbach C, Klarmann-Schulz U, Seidel MF Tags: Lupus Source Type: research

Nuclear magnetic resonance-based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis.
PMID: 32299281 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 16, 2020 Category: Rheumatology Authors: Ganguly S, Kumar U, Gupta N, Guleria A, Majumdar S, Phatak S, Chaurasia S, Kumar S, Aggarwal A, Kumar D, Misra R Tags: Lupus Source Type: research

Seroconversion to antinuclear antibody negativity and its association with disease flare in patients with systemic lupus erythematosus.
PMID: 32279583 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 11, 2020 Category: Rheumatology Authors: Kwon OC, Kim YG, Park JH, Park MC Tags: Lupus Source Type: research

Global antiphospholipid syndrome score and anti- ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.
Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study. Lupus. 2020 Apr 11;:961203320916527 Authors: Nascimento IS, Radin M, Gândara APR, Sciascia S, de Andrade DCO PMID: 32279584 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 11, 2020 Category: Rheumatology Authors: Nascimento IS, Radin M, Gândara APR, Sciascia S, de Andrade DCO Tags: Lupus Source Type: research

CD4+CD28null T cells are expanded in moderately active systemic lupus erythematosus and secrete pro-inflammatory interferon gamma, depending on the Disease Activity Index.
PMID: 32279585 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 11, 2020 Category: Rheumatology Authors: Kosmaczewska A, Ciszak L, Stosio M, Szteblich A, Madej M, Frydecka I, Wiland P, Szmyrka M Tags: Lupus Source Type: research

Inflammatory myositis in systemic lupus erythematosus.
PMID: 32281474 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 11, 2020 Category: Rheumatology Authors: Bitencourt N, Solow EB, Wright T, Bermas BL Tags: Lupus Source Type: research

Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity.
PMID: 32264742 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 7, 2020 Category: Rheumatology Authors: Hirahara S, Katsumata Y, Kawasumi H, Kawaguchi Y, Harigai M Tags: Lupus Source Type: research

Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature.
PMID: 32252584 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 6, 2020 Category: Rheumatology Authors: Skoczynska M, Crowther MA, Chowaniec M, Ponikowska M, Chaturvedi S, Legault K Tags: Lupus Source Type: research

Obituary: Jorge Martins (1954-2020).
PMID: 32252588 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 6, 2020 Category: Rheumatology Authors: Barros C, Cervera R Tags: Lupus Source Type: research

Interleukin-34 as a marker for subclinical proliferative lupus nephritis.
PMID: 32237962 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - April 1, 2020 Category: Rheumatology Authors: Abdel-Rehim AS, Mohamed NA, Shakweer MM Tags: Lupus Source Type: research

Clinical implications of IL-10 promoter polymorphisms on disease susceptibility in Indian SLE patients.
PMID: 32233730 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 31, 2020 Category: Rheumatology Authors: Umare V, Pradhan V, Dadheech S, Rajadhyaksha A, Ghosh K, Nadkarni A Tags: Lupus Source Type: research

Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
CONCLUSIONS: Disease presentations and laboratory findings vary significantly between age groups within a national cohort of JSLE patients. Patients diagnosed during adolescence exhibit greater disease activity and "classic" autoantibody, immune cell and complement patterns when compared with younger patients. This supports the hypothesis that pathomechanisms may vary between patient age groups. PMID: 32233733 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 31, 2020 Category: Rheumatology Authors: Massias JS, Smith EMD, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford Tags: Lupus Source Type: research

Occurrence, predictors and outcome of infections at three months in hospitalized patients with SLE: A prospective study from Southern India.
PMID: 32223510 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 29, 2020 Category: Rheumatology Authors: Alur S, Mary Thabah M, Sistla S, Singh Negi V Tags: Lupus Source Type: research

Catastrophic antiphospholipid syndrome following the introduction of rivaroxaban.
PMID: 32223511 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 29, 2020 Category: Rheumatology Authors: Stammler R, Legendre P, Cacoub P, Blanche P, Piette JC, Costedoat-Chalumeau N Tags: Lupus Source Type: research

Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis.
PMID: 32216516 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 26, 2020 Category: Rheumatology Authors: Kinloch AJ, Cascino MD, Dai J, Bermea RS, Ko K, Vesselits M, Dragone LL, Mor Vaknin N, Legendre M, Markovitz DM, Okoreeh MK, Townsend MJ, Clark MR Tags: Lupus Source Type: research

A comparison of the performance of the 2019 European League Against Rheumatism/American College of Rheumatology criteria and the 2012 Systemic Lupus International Collaborating Clinics criteria with the 1997 American College of Rheumatology classification criteria for systemic lupus erythematous in new-onset Chinese patients.
PMID: 32216517 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 26, 2020 Category: Rheumatology Authors: Teng J, Ye J, Zhou Z, Lu C, Chi H, Cheng X, Liu H, Su Y, Shi H, Sun Y, Yang C Tags: Lupus Source Type: research

Audiological disturbances in patients with primary antiphospholipid syndrome.
PMID: 32208956 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 25, 2020 Category: Rheumatology Authors: Erez D, Abarbuch E, Natour A, Meyer A, Natour A, Dovrish Z, Levy Y Tags: Lupus Source Type: research

Obesity increases the incidence of new-onset lupus nephritis and organ damage during follow-up in patients with systemic lupus erythematosus.
PMID: 32208798 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 24, 2020 Category: Rheumatology Authors: Kang JH, Xu H, Choi SE, Park DJ, Lee JK, Kwok SK, Kim SK, Choe JY, Kim HA, Sung YK, Shin K, Lee SS Tags: Lupus Source Type: research

Diagnostic value of urinary monocyte chemoattractant protein-1 in evaluating the activity of lupus nephritis: a meta-analysis.
PMID: 32208799 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 24, 2020 Category: Rheumatology Authors: Xia YR, Li QR, Wang JP, Guo HS, Bao YQ, Mao YM, Wu J, Pan HF, Ye DQ Tags: Lupus Source Type: research

Cutaneous squamous cell carcinoma causing a rhinophymatous mass in a patient with clinically occult hypertrophic lupus erythematosus.
PMID: 32202198 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 22, 2020 Category: Rheumatology Authors: Cohen L, Shah V, Chen PL, Messina J, Seminario-Vidal L Tags: Lupus Source Type: research

Understanding the dynamics of hydroxychloroquine blood levels in lupus nephritis.
PMID: 32192398 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 19, 2020 Category: Rheumatology Authors: Pedrosa TN, Pasoto SG, Aikawa NE, Yuki EF, Borba EF, Filho JCF, Carricondo PC, Zanetti CB, Conde PG, Duarte NJ, Fontoura N, Romano P, Carvalho VM, Silva CA, Bonfa E Tags: Lupus Source Type: research

Successful treatment of refractory lupus erythematosus profundus with the interleukin-6 antagonist tocilizumab: a case report.
PMID: 32192399 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 19, 2020 Category: Rheumatology Authors: Elolemy G, Al Rashidi A, Dehrab A, Almathkouri A, Varghese A, Chikhly M, Alkhawaja F Tags: Lupus Source Type: research

Biosimilars.
PMID: 32188301 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 18, 2020 Category: Rheumatology Authors: Edwards CJ, Bellinvia S Tags: Lupus Source Type: research

Gastrointestinal vasculitis due to systemic lupus erythematosus treated with rituximab: a case report.
Koca SS PMID: 32188302 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 18, 2020 Category: Rheumatology Authors: Kenar G, Atay K, Yüksek GE, Öz B, Koca SS Tags: Lupus Source Type: research

Erythrocyte membrane polyunsaturated fatty acid profiles are associated with systemic inflammation and fish consumption in systemic lupus erythematosus: a cross-sectional study.
hebb NH PMID: 32188303 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 18, 2020 Category: Rheumatology Authors: Vordenbäumen S, Sokolowski A, Kutzner L, Rund KM, Düsing C, Chehab G, Richter JG, Brinks R, Schneider M, Schebb NH Tags: Lupus Source Type: research

Relationship between remission, disease activity and patient-reported outcome measures in patients with recent-onset systemic lupus erythematosus.
;wall C PMID: 32188304 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 18, 2020 Category: Rheumatology Authors: Heijke R, Björk M, Frodlund M, McDonald L, Alemao E, Sjöwall C Tags: Lupus Source Type: research

Plasma immunoglobulin binding protein 1 as a predictor of development of lupus nephritis.
PMID: 32183589 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 17, 2020 Category: Rheumatology Authors: Kwon OC, Lee EJ, Oh JS, Hong S, Lee CK, Yoo B, Park MC, Kim YG Tags: Lupus Source Type: research

Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand.
PMID: 32183590 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 17, 2020 Category: Rheumatology Authors: Juthong S, Geater AF, Dekumyoy P, Hortiwakul T, Siripaitoon B, Aiewruengsurat D, Thongbun N Tags: Lupus Source Type: research

Factor Xa inhibitors for preventing recurrent thrombosis in patients with antiphospholipid syndrome: additional information.
PMID: 32151179 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 9, 2020 Category: Rheumatology Authors: Letic M Tags: Lupus Source Type: research

Associations of four common VDR polymorphisms with rheumatoid arthritis and systemic lupus erythematosus: evidence from a meta-analysis.
Abstract Associations of polymorphisms in vitamin D receptor (VDR) with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) have already been explored by many studies. The aim of this meta-analysis was to better clarify associations between polymorphisms in VDR and RA/SLE by combing the results of all relevant studies. Eligible studies were searched from Pubmed, Embase, WOS and CNKI. We used Review Manager to combine the results of eligible studies. Thirty-seven studies were included in this meta-analysis. VDR rs1544410 (recessive comparison: odds ratio (OR) = 1.36, 95% confidence interv...
Source: Lupus - March 9, 2020 Category: Rheumatology Authors: Zhang WT, Jin TF, Chen L Tags: Lupus Source Type: research

Corrigendum to Aquaporin-4 IgG antibody-related disorders in patients with juvenile systemic lupus erythematosus.
Authors: PMID: 32151181 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 9, 2020 Category: Rheumatology Tags: Lupus Source Type: research

Stroke in systemic lupus erythematosus: epidemiology, mechanism, and long-term outcome.
CONCLUSIONS: The prevalence of stroke in this cohort was 3.1%. Ischemic strokes had a bimodal presentation, occurring either early after SLE diagnosis or after a several-year delay. Half of the hemorrhagic strokes occurred>10 years after the diagnosis of SLE. Clinical outcome was usually good with a relatively low recurrence rate. PMID: 32151182 [PubMed - as supplied by publisher] (Source: Lupus)
Source: Lupus - March 9, 2020 Category: Rheumatology Authors: Guraieb-Chahín P, Cantú-Brito C, Soto-Mota A, Guerrero-Torres L, Flores-Silva F, Chiquete E, Fragoso-Loyo H, González-Duarte A, Valdés-Ferrer SI Tags: Lupus Source Type: research